TY - JOUR
T1 - Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non–Small-Cell Lung Cancer
T2 - Who are the Optimal Candidates?
AU - Wu, Trudy C.
AU - Smith, Lauren M.
AU - Woolf, David
AU - Faivre-Finn, Corinne
AU - Lee, Percy
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2024/1
Y1 - 2024/1
N2 - The landscape of lung radiotherapy (RT) has rapidly evolved over the past decade with modern RT and surgical techniques, systemic therapies, and expanding indications for RT. To date, 2 MRI-guided RT (MRgRT) units, 1 using a 0.35T magnet and 1 using a 1.5T magnet, are available for commercial use with more systems in the pipeline. MRgRT offers distinct advantages such as real-time target tracking, margin reduction, and on-table treatment adaptation, which may help overcome many of the common challenges associated with thoracic RT. Nonetheless, the use of MRI for image guidance and the current MRgRT units also have intrinsic limitations. In this review article, we will discuss clinical experiences to date, advantages, challenges, and future directions of MRgRT to the lung.
AB - The landscape of lung radiotherapy (RT) has rapidly evolved over the past decade with modern RT and surgical techniques, systemic therapies, and expanding indications for RT. To date, 2 MRI-guided RT (MRgRT) units, 1 using a 0.35T magnet and 1 using a 1.5T magnet, are available for commercial use with more systems in the pipeline. MRgRT offers distinct advantages such as real-time target tracking, margin reduction, and on-table treatment adaptation, which may help overcome many of the common challenges associated with thoracic RT. Nonetheless, the use of MRI for image guidance and the current MRgRT units also have intrinsic limitations. In this review article, we will discuss clinical experiences to date, advantages, challenges, and future directions of MRgRT to the lung.
UR - http://www.scopus.com/inward/record.url?scp=85176607547&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85176607547&partnerID=8YFLogxK
U2 - 10.1016/j.semradonc.2023.10.007
DO - 10.1016/j.semradonc.2023.10.007
M3 - Review article
C2 - 38105094
AN - SCOPUS:85176607547
SN - 1053-4296
VL - 34
SP - 56
EP - 63
JO - Seminars in radiation oncology
JF - Seminars in radiation oncology
IS - 1
ER -